NSE, which is involved in neuronal glycolysis, has been considered as a direct biomarker to assess functional neuronal damage in several neuronal pathologies including TBI, HD-like rat model and experimental epilepsy model (Baraka et al. 2012; Ramirez et al. 2021; Virdi et al. 2021). This evidence concerns the gene ENO2 and Huntington disease.